Jeffrey S Jackel, MD | |
639 Granite St Ste 215, Braintree, MA 02184-5371 | |
(781) 817-5383 | |
Not Available |
Full Name | Jeffrey S Jackel |
---|---|
Gender | Male |
Speciality | Pain Management |
Experience | 42 Years |
Location | 639 Granite St Ste 215, Braintree, Massachusetts |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1215915327 | NPI | - | NPPES |
3001253 | Medicaid | MA |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Blue Hill Pain Care Pllc | 8224251053 | 2 |
Jjm Medical Services Pc | 6800950312 | 54 |
News Archive
EffRx Pharmaceuticals SA today announced that the U.S. Food and Drug Administration (FDA) has approved BINOSTO (alendronate sodium) Effervescent Tablets, previously known as EX101, for the treatment of osteoporosis in postmenopausal women, and as a treatment to increase bone mass in men with osteoporosis. EffRx anticipates that BINOSTO will be commercially available in the United States in the third quarter of 2012.
With tens of thousands of people set to travel abroad over the Christmas period, AA Travel Insurance are today urging travellers to be properly vaccinated before travelling.
Freescale Semiconductor is expanding its 8-bit microcontroller (MCU) portfolio with devices ideal for personal diagnostic and portable health care products that require low-power operation and advanced display capabilities.
For more than 5 million Americans with heart failure, a critical step to better health is taking the medications they're prescribed. But many patients fail to do so, putting themselves at greater risk of hospitalization and even death. To date, studies have not fully answered why patients fall short when it comes to taking heart medicine. In a study appearing in the April issue of Mayo Clinic Proceedings, Mayo Clinic researchers found the drugs' cost is one of the biggest deterrents.
› Verified 6 days ago
Entity Name | New England Eye Surgical Assoc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1760449979 PECOS PAC ID: 2466431853 Enrollment ID: O20040719000827 |
News Archive
EffRx Pharmaceuticals SA today announced that the U.S. Food and Drug Administration (FDA) has approved BINOSTO (alendronate sodium) Effervescent Tablets, previously known as EX101, for the treatment of osteoporosis in postmenopausal women, and as a treatment to increase bone mass in men with osteoporosis. EffRx anticipates that BINOSTO will be commercially available in the United States in the third quarter of 2012.
With tens of thousands of people set to travel abroad over the Christmas period, AA Travel Insurance are today urging travellers to be properly vaccinated before travelling.
Freescale Semiconductor is expanding its 8-bit microcontroller (MCU) portfolio with devices ideal for personal diagnostic and portable health care products that require low-power operation and advanced display capabilities.
For more than 5 million Americans with heart failure, a critical step to better health is taking the medications they're prescribed. But many patients fail to do so, putting themselves at greater risk of hospitalization and even death. To date, studies have not fully answered why patients fall short when it comes to taking heart medicine. In a study appearing in the April issue of Mayo Clinic Proceedings, Mayo Clinic researchers found the drugs' cost is one of the biggest deterrents.
› Verified 6 days ago
Entity Name | Cap Anesthesia, Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1497763213 PECOS PAC ID: 8820090269 Enrollment ID: O20070214000051 |
News Archive
EffRx Pharmaceuticals SA today announced that the U.S. Food and Drug Administration (FDA) has approved BINOSTO (alendronate sodium) Effervescent Tablets, previously known as EX101, for the treatment of osteoporosis in postmenopausal women, and as a treatment to increase bone mass in men with osteoporosis. EffRx anticipates that BINOSTO will be commercially available in the United States in the third quarter of 2012.
With tens of thousands of people set to travel abroad over the Christmas period, AA Travel Insurance are today urging travellers to be properly vaccinated before travelling.
Freescale Semiconductor is expanding its 8-bit microcontroller (MCU) portfolio with devices ideal for personal diagnostic and portable health care products that require low-power operation and advanced display capabilities.
For more than 5 million Americans with heart failure, a critical step to better health is taking the medications they're prescribed. But many patients fail to do so, putting themselves at greater risk of hospitalization and even death. To date, studies have not fully answered why patients fall short when it comes to taking heart medicine. In a study appearing in the April issue of Mayo Clinic Proceedings, Mayo Clinic researchers found the drugs' cost is one of the biggest deterrents.
› Verified 6 days ago
Entity Name | Arbour Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1770766529 PECOS PAC ID: 6800975574 Enrollment ID: O20080506000660 |
News Archive
EffRx Pharmaceuticals SA today announced that the U.S. Food and Drug Administration (FDA) has approved BINOSTO (alendronate sodium) Effervescent Tablets, previously known as EX101, for the treatment of osteoporosis in postmenopausal women, and as a treatment to increase bone mass in men with osteoporosis. EffRx anticipates that BINOSTO will be commercially available in the United States in the third quarter of 2012.
With tens of thousands of people set to travel abroad over the Christmas period, AA Travel Insurance are today urging travellers to be properly vaccinated before travelling.
Freescale Semiconductor is expanding its 8-bit microcontroller (MCU) portfolio with devices ideal for personal diagnostic and portable health care products that require low-power operation and advanced display capabilities.
For more than 5 million Americans with heart failure, a critical step to better health is taking the medications they're prescribed. But many patients fail to do so, putting themselves at greater risk of hospitalization and even death. To date, studies have not fully answered why patients fall short when it comes to taking heart medicine. In a study appearing in the April issue of Mayo Clinic Proceedings, Mayo Clinic researchers found the drugs' cost is one of the biggest deterrents.
› Verified 6 days ago
Entity Name | Jjm Medical Services Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1952548265 PECOS PAC ID: 6800950312 Enrollment ID: O20090128000435 |
News Archive
EffRx Pharmaceuticals SA today announced that the U.S. Food and Drug Administration (FDA) has approved BINOSTO (alendronate sodium) Effervescent Tablets, previously known as EX101, for the treatment of osteoporosis in postmenopausal women, and as a treatment to increase bone mass in men with osteoporosis. EffRx anticipates that BINOSTO will be commercially available in the United States in the third quarter of 2012.
With tens of thousands of people set to travel abroad over the Christmas period, AA Travel Insurance are today urging travellers to be properly vaccinated before travelling.
Freescale Semiconductor is expanding its 8-bit microcontroller (MCU) portfolio with devices ideal for personal diagnostic and portable health care products that require low-power operation and advanced display capabilities.
For more than 5 million Americans with heart failure, a critical step to better health is taking the medications they're prescribed. But many patients fail to do so, putting themselves at greater risk of hospitalization and even death. To date, studies have not fully answered why patients fall short when it comes to taking heart medicine. In a study appearing in the April issue of Mayo Clinic Proceedings, Mayo Clinic researchers found the drugs' cost is one of the biggest deterrents.
› Verified 6 days ago
Entity Name | Blue Hill Pain Care Pllc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1861823783 PECOS PAC ID: 8224251053 Enrollment ID: O20140524000032 |
News Archive
EffRx Pharmaceuticals SA today announced that the U.S. Food and Drug Administration (FDA) has approved BINOSTO (alendronate sodium) Effervescent Tablets, previously known as EX101, for the treatment of osteoporosis in postmenopausal women, and as a treatment to increase bone mass in men with osteoporosis. EffRx anticipates that BINOSTO will be commercially available in the United States in the third quarter of 2012.
With tens of thousands of people set to travel abroad over the Christmas period, AA Travel Insurance are today urging travellers to be properly vaccinated before travelling.
Freescale Semiconductor is expanding its 8-bit microcontroller (MCU) portfolio with devices ideal for personal diagnostic and portable health care products that require low-power operation and advanced display capabilities.
For more than 5 million Americans with heart failure, a critical step to better health is taking the medications they're prescribed. But many patients fail to do so, putting themselves at greater risk of hospitalization and even death. To date, studies have not fully answered why patients fall short when it comes to taking heart medicine. In a study appearing in the April issue of Mayo Clinic Proceedings, Mayo Clinic researchers found the drugs' cost is one of the biggest deterrents.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Jeffrey S Jackel, MD 639 Granite St Ste 215, Braintree, MA 02184-5371 Ph: (781) 817-5383 | Jeffrey S Jackel, MD 639 Granite St Ste 215, Braintree, MA 02184-5371 Ph: (781) 817-5383 |
News Archive
EffRx Pharmaceuticals SA today announced that the U.S. Food and Drug Administration (FDA) has approved BINOSTO (alendronate sodium) Effervescent Tablets, previously known as EX101, for the treatment of osteoporosis in postmenopausal women, and as a treatment to increase bone mass in men with osteoporosis. EffRx anticipates that BINOSTO will be commercially available in the United States in the third quarter of 2012.
With tens of thousands of people set to travel abroad over the Christmas period, AA Travel Insurance are today urging travellers to be properly vaccinated before travelling.
Freescale Semiconductor is expanding its 8-bit microcontroller (MCU) portfolio with devices ideal for personal diagnostic and portable health care products that require low-power operation and advanced display capabilities.
For more than 5 million Americans with heart failure, a critical step to better health is taking the medications they're prescribed. But many patients fail to do so, putting themselves at greater risk of hospitalization and even death. To date, studies have not fully answered why patients fall short when it comes to taking heart medicine. In a study appearing in the April issue of Mayo Clinic Proceedings, Mayo Clinic researchers found the drugs' cost is one of the biggest deterrents.
› Verified 6 days ago